Page last updated: 2024-08-26
desethylamiodarone and Liver Dysfunction
desethylamiodarone has been researched along with Liver Dysfunction in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Agoston, M; Blázovics, A; Fehér, E; Fehér, J; Hagymási, K; Orosz, Z; Orsi, F; Vereckei, A | 1 |
| Carruthers, SG; Pollak, PT; Sharma, AD | 1 |
Other Studies
2 other study(ies) available for desethylamiodarone and Liver Dysfunction
| Article | Year |
|---|---|
Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats.
Topics: Amiodarone; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Hepatocytes; Liver Diseases; Lysosomes; Male; Microscopy, Electron; Phospholipids; Random Allocation; Rats; Rats, Inbred F344; Silymarin; Thiobarbituric Acid Reactive Substances; Vitamin E | 2003 |
Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.
Topics: Alanine Transaminase; Amiodarone; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Female; Humans; Liver Diseases; Lung Diseases; Male; Middle Aged; Pulmonary Diffusing Capacity; Superoxide Dismutase | 1990 |